BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 7082992)

  • 1. A post-mortem study of the cholinergic and GABA systems in senile dementia.
    Rossor MN; Garrett NJ; Johnson AL; Mountjoy CQ; Roth M; Iversen LL
    Brain; 1982 Jun; 105(Pt 2):313-30. PubMed ID: 7082992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls.
    Nagai T; McGeer PL; Peng JH; McGeer EG; Dolman CE
    Neurosci Lett; 1983 Apr; 36(2):195-9. PubMed ID: 6866327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients.
    Henke H; Lang W
    Brain Res; 1983 May; 267(2):281-91. PubMed ID: 6871677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.
    Rossor MN; Svendsen C; Hunt SP; Mountjoy CQ; Roth M; Iversen LL
    Neurosci Lett; 1982 Feb; 28(2):217-22. PubMed ID: 7070710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.
    Lippa CF; Smith TW; Perry E
    J Neural Transm (Vienna); 1999; 106(5-6):525-35. PubMed ID: 10443555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Davies P; Terry RD
    Neurobiol Aging; 1981; 2(1):9-14. PubMed ID: 6115327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia.
    Mountjoy CQ; Rossor MN; Iversen LL; Roth M
    Brain; 1984 Jun; 107 ( Pt 2)():507-18. PubMed ID: 6722514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of brain choline acetyltransferase activity in Alzheimer's disease, multi-infarct dementia, and combined dementia.
    Rinne JO; Säkö E; Paljärvi L; Mölsä PK; Rinne UK
    J Neural Transm; 1988; 73(2):121-8. PubMed ID: 3210004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of choline acetyltransferase activity between the nucleus basalis of Meynert and the cerebral cortex.
    Koshimura K; Kato T; Yohyama I; Nakamura S; Kameyama M
    Neurosci Res; 1987 Apr; 4(4):330-6. PubMed ID: 3601249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.
    Rossor M; Fahrenkrug J; Emson P; Mountjoy C; Iversen L; Roth M
    Brain Res; 1980 Nov; 201(1):249-53. PubMed ID: 7417838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
    Wilcock GK; Esiri MM; Bowen DM; Smith CC
    J Neurol Sci; 1982 Dec; 57(2-3):407-17. PubMed ID: 7161627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease.
    Lowe SL; Francis PT; Procter AW; Palmer AM; Davison AN; Bowen DM
    Brain; 1988 Aug; 111 ( Pt 4)():785-99. PubMed ID: 3401683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain.
    McGeer PL; McGeer EG; Suzuki J; Dolman CE; Nagai T
    Neurology; 1984 Jun; 34(6):741-5. PubMed ID: 6539435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative abnormalities of choline acetyltransferase in Alzheimer type dementia.
    Koshimura K; Kato T; Tohyama I; Nakamura S; Kameyama M
    J Neurol Sci; 1986 Dec; 76(2-3):143-50. PubMed ID: 3794747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients.
    Bowen DM; Benton JS; Spillane JA; Smith CC; Allen SJ
    J Neurol Sci; 1982 Dec; 57(2-3):191-202. PubMed ID: 7161618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choline acetyltransferase immunoreactivity in neuritic plaques of Alzheimer brain.
    Armstrong DM; Bruce G; Hersh LB; Terry RD
    Neurosci Lett; 1986 Nov; 71(2):229-34. PubMed ID: 2431362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of Alzheimer's disease and hippocampal sclerosis with normal cholinergic activity in basal forebrain, neocortex, and hippocampus.
    Zweig RM; Schegg KM; Peacock JH; Melarkey D
    Neurology; 1989 Feb; 39(2 Pt 1):288-90. PubMed ID: 2915803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.
    Perry EK; Tomlinson BE; Blessed G; Bergmann K; Gibson PH; Perry RH
    Br Med J; 1978 Nov; 2(6150):1457-9. PubMed ID: 719462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease.
    Palmer AM; Procter AW; Stratmann GC; Bowen DM
    Neurosci Lett; 1986 May; 66(2):199-204. PubMed ID: 3014387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dementia without cholinergic deficit.
    Riekkinen PJ; Soininen H; Sirviö J; Reinikainen K; Helkala EL; Paljärvi L
    Gerontology; 1987; 33(3-4):268-72. PubMed ID: 3653707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.